Brief: Prometheus Biosciences Shares Open 31.3% Above IPO Price In Debut On Nasdaq
12/03/2021 17:07
March 12 (Reuters) -
* PROMETHEUS BIOSCIENCES SHARES OPEN AT $24.95 IN DEBUT ON
NASDAQ
VERSUS IPO PRICE OF $19.00/SHARE
Further company coverage: RXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results